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ABSTRACT
An experiment was conducted using 42 IVRI 2CQ rats to evaluate the effects of three antioxidants,
ascorbic acid, l methionine or α tocopherol alone, or chelator CaNa2EDTA alone or along with
antioxidant α tocopherol, on lead accumulation, status of lipid peroxidation, and of copper and zinc
concentration in cardiac tissue of lead-treated rats. Lead was given intraperitoneally as 1% lead acetate
solution at the dose rate of 1mg of Pb2+/kg body mass for a period of 30 days. The lead was then
withdrawn and the lead-exposed rats (n=36) were randomly divided into six groups, six lead-treated
rats in each group. A further six rats were given no treatment, including lead exposure, to serve as
negative controls. The rats were sacrificed under light anaesthesia one day after one week of treatment
with antioxidant ascorbic acid, l-methionine or α tocopherol or with chelator CaNa2EDTA alone or
along with antioxidant α tocopherol. Blood samples were collected and heart was quickly excised.
Mean lead concentration in cardiac tissue was significantly higher in the lead-treated group, even
after its withdrawal for a period of seven days (5.02 ± 1.06 vs. 0.40 ± 0.09 µg/gm). The treatment with
chelator plus antioxidant α tocopherol lowered the cardiac lead burden but the level remained
significantly higher than that of the negative control. There was a non-significant increase in lipid
peroxide levels in the cardiac tissue of lead-exposed untreated rats and either of the antioxidants
lowered the lipid peroxide level, but the differences between the different treatment groups remained
statistically comparable at P>0.05. The mean concentration of copper and zinc in cardiac tissue remained
statistically comparable among the different treatment groups.
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Introduction
Lead is a common industrial and environmental pollutant. Prolonged
exposure at a sub-lethal dose to this toxicant is considered to be a risk
factor for cardiovascular diseases. It leads to elevated arterial pressure,
alteration in the cardiac conduction system and degenerative changes of
cardiac musculature, swelling of the Purkinjee fibers and decreased
contractility (ASHOKAN, 1974; DEY et al., 1993; TSAO et al., 2000). Recent studies
(BENER et al., 2001; VAZIRI et al., 2001) revealed that lead-associated
hypertension was due in part to increased generation of reactive oxygen
species (ROS), particularly increased hydroxyl radical production,
suggesting that lead-induced cardiac damage may occur as a consequence
of the propensity of lead to disturb the delicate pro-oxidant and antioxidant
balance in the cardiac tissue.
Lead accumulates in almost every tissue, including heart, following
experimental feeding (SINGH et al., 1976; FICK et al., 1976). Conventional
therapeutic management includes chelation of lead from accumulated
tissue. However, recent implication of oxidative stress contributing to lead-
associated tissue injury suggests incorporation of antioxidants for better
therapeutic management (HALLIWELL, 1994; PATRA et al., 2001). Use of
antioxidants in vitro proved beneficial in protecting cells from oxidative
damage (ERCAL et al., 1996). The present study evaluates the lead burden
and status of lipid peroxidation and components of important antioxidant
enzymes copper and zinc in cardiac tissue after treatment of lead-exposed
rats with ascorbic acid, l-methionine or ∝tocopherol, chelator CaNa2EDTA
alone or along with antioxidant α tocopherol.
Materials and methods
Animals and experimental design. The experiment was performed using
42 IVRI 2CQ male and female rats sexes weighing about 100 g. Rats were
maintained in rat cages in the laboratory animal shed of the division, fed
with laboratory animal feed and were provided with water ad libitum.
Experimental animals were acclimatized to their housing environment one
month before the start of the experiment. Six rats received a daily i.p.
injection of sterile normal saline solution for a period of 30 days to serve
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as control. The remaining 36 rats were administered with 1 mg Pb2+ /kg
body mass as 0.924% lead acetate (99% pure) solution i.p. for a period of
30 days. The lead and NSS administration were then withdrawn and lead-
exposed rats were divided equally into 6 groups. During the next week,
rats of each group were either treated with ascorbic acid, l-methionine, or
α tocopherol at a daily dose of 100 mg/kg body orally for 7 days, or with
CaNa2EDTA alone at a dose rate of 110 mg/kg-body mass/day
intraperitoneally in two divided doses for 4 days, or chelator along with α
tocopherol. Those that received no treatment served as positive controls.
Animals of different groups were sacrificed under light anaesthesia
one day after the end of the treatment, and the blood was collected from
heart. The heart was then quickly excised. Half of the heart was processed
immediately for measurement of lipid peroxides level, and the other half
was stored at -20 oC for wet digestion, for estimation of lead, copper and
zinc content. The blood samples were also wet digested for estimation of
lead level (KOLMER et al., 1951).
 Biochemical analysis. Lipid peroxides level was estimated through
measuring malondialdhyde (MDA) concentration in the cardiac tissue
(OHKAWA et al., 1979). This is a useful method for determination of extent
of lipid peroxidation, as it is the most abundant aldehyde formed as a by-
product during this process (GURER et al., 1998). The values were expressed
in nmol of MDA/g of wet tissue using the extinction coefficient of 1.56 x
105 /M/cm (UTLEY et al., 1967).
Analyses of toxic heavy metal and trace elements. The digested samples
were analysed for estimation of lead, copper and zinc in the cardiac tissue,
and for lead in the blood. The concentration of lead, copper and zinc was
measured using absorption spectrophotometer (AAS 4129, Electronic
Corporation of India Limited) at 217, 324.7, 239.5 nm wavelength and 6,
5 and 5ma current, respectively, and values were expressed in µg/ml of
blood or µg/g of tissue.
Statistical analysis. The data was statistically analysed using one-way
analysis of variance to compare the means of different treatment groups
(SNEDECOR and COCHRAN, 1994).
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Results
Blood lead concentration in animals administered lead intraperitoneally
for 30 days and given no treatment for the next week (0.68 ± 0.04 µg/ml)
remained significantly (P<0.05) higher than that of control animals (0.09
± 0.01 µg/ml). Neither of the treatments with antioxidant or chelator after
the end of the lead exposure lowered the blood lead burden to be statistically
(P<0.05) comparable to the control animals. The maximum reduction in
blood lead level was recorded in rats treated with l-methionine (0.46 ±
0.01µg/ml) followed by EDTA plus α tocopherol (0.64 ± 0.09 µg/ml) and
EDTA alone (0.65 ± 0.09 µg/ml). However, treatment with ascorbic acid
for 7 days enhanced the blood lead concentration (0.94 ± 0.12 µg/ml) and
the mean level was significantly (P<0.05) higher than the rest of the lead-
exposed treated groups (Fig. 1).
Fig. 1. Blood lead level in lead-exposed rats given treatment with antioxidant alone,

































Table 1 shows the lead burden, lipid peroxides level and copper and
zinc concentrations in heart from different therapeutic groups. There was
an approximately 13-fold rise in heart lead concentration (5.02 ± 1.06 µg/
g) in lead-exposed untreated rats compared to unexposed controls (0.40 ±
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0.09 µg/g). The maximum reduction in tissue lead burden was recorded in
animals treated with chelator plus α tocopherol (2.54 ± 0.54 µg/g) followed
by chelator alone (3.32 ± 0.72 µg/g), but the tissue concentration in
treatment groups remained statistically (P<0.05) comparable to lead
exposed untreated group and was significantly higher than that of the
unexposed group.
The lipid peroxide level, as determined in terms of nmol of MDA
produced/g wet tissue, was non-significantly (P<0.05) higher in rats
exposed to lead for 30 days and followed by withdrawal period of next 7
days of treatment duration. The maximum decline (15.4%) in lipid peroxide
level in cardiac tissue was recorded in lead-exposed rats treated with
chelator plus antioxidant. However, the deteriorative changes in lipids due
to oxidative damage were statistically comparable in all groups. Copper
and zinc concentration in all treatment groups, including animals given no
lead exposure, remained statistically (P<0.05) comparable.
Discussion
Lead is a pervasive environmental pollutant that accumulates in almost
all tissues (DOYLE and YOUNGER, 1984) and with no beneficial biological
Groups Heart Pb  (µg/ml) 
Lipid peroxide 





Control 0.40a  ± 0.09 211.1 ± 7.9 7.09 ± 0.99 19.74 ± 2.58 
Pb 5.02 cd ± 1.06 254.0 ± 19.0 8.23 ± 1.49 20.04 ± 1.83 
Pb+ Asc 5.01 cd ± 1.10 237.9 ± 15.3 7.92 ± 1.15 20.48 ± 1.78 
Pb +∝T 4.21 bcd ± 0.27 217.4 ± 18.3 8.74 ± 1.06 20.44 ± 2.47 
Pb + M 6.17 d ± 1.15 221.1 ± 23.0 7.00 ± 0.50 20.06 ± 2.61 
Pb + EDTA 3.32 bc ± 0.76 254.4 ± 23.0 6.68 ± 0.56 22.06 ± 2.67 
Pb EDTA+∝T 2.54 bc ± 0.54 214.8 ± 12.5 7.38 ± 1.06 23.18 ± 3.75 
 
Table 1. Cardiac lead, lipid peroxide level and copper, and zinc concentration in lead-
treated rats after treatment*
*Lead was given at a daily dose of 1 mg/kg body mass for 30 days. Then the lead was
withdrawn and the lead exposed rats (n = 36) rats are divided into 6 equal groups. Ascorbic
acid (Asc), L-Methionine (M), or α tocopherol (αT) was given for a period of 7 days at the
dose rate of 100 mg/kg body mass or chelator CaNa2EDTA (EDTA) was given 110 mg/kg
body mass in two divided doses i. p. for 4 days either alone or along with α tocopherol.
Values with different superscripts column-wise differ significantly at P<0.05.
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role. Chronic occupational or experimental lead exposure is a risk factor
for cardiac diseases and there is a direct relationship between level of
exposure and cardiac diseases (BENER et al., 2001). In the present
investigation, exposure to lead for a period of 30 days, followed by a period
of 7 days of no treatment, led to manifold increases in lead concentration
in heart. SINGH et al. (1976) recorded dose-related accumulation of most
lead in heart and kidney in newborn rat pups born from the mating of, and
nourished by, experimentally lead-poisoned mothers.
The higher concentrations of lead in tissues following occupational or
experimental exposure were associated with oxidative damage of DNA,
protein and lipids and is has been suggested that lead-induced oxidative
stress plays a role in lead-induced toxic effects (MONTEIRO et al., 1985; GURER
et al., 1998; PATRA et al., 2001). BENER et al. (2001) recorded a significant
association between lead exposure, high blood pressures and risk of heart
diseases. Previous animal studies have suggested lead associated oxidative
stress in liver and brain (SANDHIR et al., 1994; SANDHIR and GILL 1995; ERCAL
et al., 1996). In vitro studies have also indicated the potential of lead in
disturbing the pro-oxidant and antioxidant balance (QUINLAN et al., 1988).
The resultant oxidative stress, particularly the generation of peroxyl
radicals, induces lipid peroxidation, a basic cellular deteriorative change
that occurs readily in tissues due to presence of membrane rich in
polyunsaturated highly oxidizable fatty acids (CINI et al., 1994). Our earlier
studies also revealed increased lipid peroxidation in liver and brain, but
not in kidneys following experimental lead intoxication (PATRA et al., 2001).
The present finding of a non-significant increase in LPO level in heart
might be due to comparatively low oxidizable fatty acids content in heart.
Conventional chelator CaNa2EDTA has long been used for treatment
of lead poisoning. The involvement of lead in inducing oxidative stress in
liver and brain and the poor chelating ability of this chelator to reduce soft
tissue lead burden and its inherent toxicity (CORYSLECHTA et al., 1987)
necessitates incorporation of antioxidants for improving therapeutic results
(ERCAL et al., 1996). The beneficial role of several vitamins, including
ascorbic acid, has been investigated but without being assessed for its
potential in ameliorating lead-induced oxidative stress (VIJ et al., 1998, HSU
et al., 1998). Vitamin C has earlier been reported as a possible lead chelator
241
R. C. Patra and D. Swarup: Effect of antioxidant ascorbic acid, l-methionine or α tocopherol alone
or along with chelator on cardiac tissue of lead-treated rats
Vet. arhiv 74 (3), 235-244, 2004
with a potency similar to that of EDTA (GOYER and CHERION, 1979). In
addition, vitamin C is also a low molecular mass antioxidant that interacts
directly with oxidizing radicals (JONES et al., 1995). The lipid soluble
antioxidant α tocopherol checks lipid peroxidation through limiting the
propagation of lipid peroxidation (BUETTER, 1993) while methionine serves
as a precursor for low molecular mass antioxidant glutathione (MEISTER,
1981). In the present study none of the antioxidants alone, chelator or
chelator plus tocopherol, could significantly (P<0.05) reduce the cardiac
tissue lead burden, and lead concentration in the treatment groups remained
statistically (P>0.05) comparable to the lead-exposed, untreated group.
However, there was maximum reduction (49%) in lead level in groups
treated with chelator plus tocopherol followed by chelator alone (34%).
This substantiates the earlier finding of reduced mortality in hen
supplemented with vitamin E in the feed during concurrent exposure to
lead and selenium (KHAN et al., 1993)
Copper and zinc are essential components of antioxidant enzymes of
the body that play an important role in the prevention of free radical-induced
damage to tissues (EVANS and HALLIWELL, 2001). The concentration of such
micronutrients in tissue is expected to change due to over utilization of
these enzymes, or through regulation of synthesis. Zinc, too, protects the
peroxidation of membrane lipids, possibly by displacing bound transition
metal ions (BETTIGER et al., 1980). In the present study there was no
significant (P<0.05) change in copper or zinc concentrations among the
different treatment groups. Tissue-specific changes in micronutrient profile
have earlier been reported in cattle experimentally exposed to lead (DOYLE
and YOUNGER, 1984). Our earlier work on young calves showed alterations
in trace mineral concentration in blood during the period of lead exposure
(PATRA et al., 2001). SHAABAN et al. (1992) recorded significant correlation
between lead and other metals in different tissues. A significant decrease
in zinc and copper concentration in heart was recorded in calves
administered through the oral route with comparatively higher and toxic
doses of lead as compared to the present investigation (FICK et al., 1976).
That might have led to reduced absorption of micronutrients from the
gastrointestinal tract, besides interaction of lead and trace minerals at tissue
level. It is concluded from the study that treatment of lead-exposed rats
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SAŽETAK
U pokusu su korištena 42 štakora IVRI 2CQ.  Cilj je bio utvrditi uèinke antioksidanata askorbinske
kiseline, l-metionina i α tokoferola na nakupljanje olova, peroksidaciju lipida te koncentraciju bakra
i cinka u srèanom tkivu nakon davanja olova. Osim toga, isti pokazatelji analizirani su nakon aplikacije
kelata CaNa2EDTA zasebno, odnosno u kombinaciji s α tokoferolom. Olovo je aplicirano
intraperitonealno u obliku 1% otopine olovnoga acetata, u dozi od 1 mg Pb2+ na kilogram tjelesne
mase tijekom razdoblja od 30 dana. Nakon prestanka davanja olova, štakori (n = 36) su sluèajnim
odabirom razdijeljeni u šest skupina po šest jedinki u svakoj skupini. Prva skupina bila je izložena
samo uèincima olova, a pet skupina su osim olova primile navedene antioksidante, kelat ili njegovu
kombinaciju s  α tokoferolom. Dodatnih šest štakora u 7. skupini nisu bili izloženi olovu, antioksidantu
ili kelatu te su poslužili kao negativna kontrola. Štakori su žrtvovani u laganoj anesteziji nakon
sedmodnevnog dobivanja olova odnosno antioksidanta i kelata. Uzeti su uzorci krvi, a odmah po
žrtvovanju izvaðeno je srce. Srednja vrijednost koncentracije olova u srèanom tkivu bila je statistièki
znaèajno viša u skupini štakora koji su dobivali olovo, èak i nakon prekida sedmodnevnog davanja
(5,02 ± 1,06 prema 0,40 ± 0,09 µg/g). Lijeèenje kelatom u kombinaciji s α tokoferolom smanjilo je
razinu olova u srèanom mišiæu, ali je ona i dalje ostala znaèajno viša u odnosu na negativnu kontrolu.
Nije utvrðeno statistièki znaèajno poveæanje razine peroksidacije lipida u srèanom tkivu štakora
izloženih samo djelovanju olova. Ni jedan antioksidant nije smanjio razinu peroksidacije lipida, a i
srednje koncentracije bakra odnosno cinka nisu se statistièki znaèajno (P>0,05) razlikovale izmeðu
skupina razlièito tretiranih štakora.
Kljuène rijeèi: olovo, antioksidant, kelat, štakor, srce
